BradRovin The Ohio State UniversityUnited States

Dr. Brad H. Rovin is the Director of the Division of Nephrology and Vice Chairman of Medicine for Research at the Ohio State University Wexner Medical Center. He is the Lee A. Hebert Distinguished Professor of Nephrology. Dr. Rovin received his Bachelor of Science in Chemical Engineering from Northwestern University in Evanston Illinois and his Doctor of Medicine from the University of Illinois Medical School in Chicago, Illinois. He completed a residency in Internal Medicine at Barnes Hospital in St. Louis Missouri, and a Fellowship in Nephrology at Washington University School of Medicine, St. Louis. Dr. Rovin studies the pathogenesis of glomerular diseases. He has a special interest in lupus nephritis. His research has focused on biomarker development for glomerular diseases. He also studies experimental therapeutics in an effort to find new treatments for glomerular diseases. Dr. Rovin established a multidisciplinary Lupus, Vasculitis and Glomerulonephritis clinic and directs an advanced fellowship in autoimmune diseases for nephrologists and rheumatologists.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/63701af96cbd813ce59a31aaa8e1655f.jpg

First Name

Brad

Last Name

Rovin

Institution

Country.

United States

Friday, February 7, 2025

Time	Session

2:15 p.m. 3:45 p.m.	HIT! High Impact Clinical Trials – What and Why AndreaViecelli Chair University of QueenslandAustralia VivekKumar Chair Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE) RajivAgarwal Oral Abstract Presenter United States Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis BradRovin Oral Abstract Presenter The Ohio State UniversityUnited States Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial KatherineTuttle Oral Abstract Presenter University of Washington School of Medicine, Division of NephrologyUnited States Brahmkamal Hall - Plenary Hall

Time

Session

2:15 p.m.

3:45 p.m.

HIT! High Impact Clinical Trials – What and Why

AndreaViecelli Chair University of QueenslandAustralia

VivekKumar Chair Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia

Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)

RajivAgarwal Oral Abstract Presenter United States
Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

BradRovin Oral Abstract Presenter The Ohio State UniversityUnited States
Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial

KatherineTuttle Oral Abstract Presenter University of Washington School of Medicine, Division of NephrologyUnited States

Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Debunking Nephrology Myths: Insights From Global Kidney Care Leaders SanjayPandya Chair Consulting Nephrologist, Wockhardt Hospital & Jalaram Hospital, RajkotIndia SreejithParameswaran Chair Professor & Head, Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India India Revisiting Kidney Biopsies: Why More Than One Can Be Beneficial BradRovin Speaker The Ohio State UniversityUnited States Genetic Testing for Kidney Disease Is Not Complicated KelsieBogyo Speaker Columbia University Irving Medical CenterUnited States Thrombotic Microangiopathy Workup: Everything You Need to Know AnujaJava Speaker WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States Dealing With Biological Variability in Albuminuria and Creatinine SusrutWaikar Speaker Boston University Chobanian and Avedisian School of Medicine, and Boston Medical CenterUnited States The Underdiagnosis of Primary Aldosteronism in Clinical Practice VivekBhalla Speaker Director, Stanford Hypertension Center; Division of Nephrology, Stanford University School of MedicineUnited States Q&A Brahmkamal Hall - Plenary Hall	The ISN-KI/KIR Editorial Fellows Session: The Best of 2024/25 Articles BradRovin Chair The Ohio State UniversityUnited States GermaineWong Chair University of SydneyAustralia PierreRonco Chair Hôpital TenonFrance Kidney International in Focus: Annual Highlights PierreRonco Speaker Hôpital TenonFrance ISN-KI Fellows: Showcasing Excellence Part 1 Eugene Yu HinChan Speaker The Chinese University of Hong Kong, Hong Kong Children's HospitalHong Kong, China ISN-KI Fellows: Showcasing Excellence Part 2 IsabelleAyoub Speaker The Ohio State UniversityUnited States ISN-KI Fellows: Showcasing Excellence Part 3 ChristophKuppe Speaker Department of Nephrology, RWTH University Aachen, GermanyGermany ISN-KI Fellows: Showcasing Excellence Part 4 GriffithPerkins Speaker Australia Q and A Kidney International Reports in Focus: Annual Highlights JaiRadhakrishnan Speaker Columbia University in the City of New YorkUnited States Kidney International Reports in Focus: Annual Highlights SumitMohan Speaker Columbia UniversityUnited States Kidney International Reports in Focus: Annual Highlights AnnaFrancis Speaker University of QueenslandAustralia Q and A Celebrating Excellence: Best Reviewer Awards Presentation BradRovin Speaker The Ohio State UniversityUnited States Recognizing the Best: Basic Science Awards for Early Career Researchers VeronicaMiguel Speaker Spanish National Centre for Cardiovascular ResearchSpain Recognizing the Best: Clinical Science Awards for Early Career Researchers MuzamilHassan Speaker Department of Medicine, Obafemi Awolowo University, Ile-Ife, NigeriaNigeria Recognizing the Best: ISN-KI Editorial Fellows Awards GermaineWong Speaker University of SydneyAustralia Champa Hall 304
2:15 p.m. 3:45 p.m.	Speed Dating with KI/KIR Editors BradRovin Chair The Ohio State UniversityUnited States GermaineWong Chair University of SydneyAustralia PierreRonco Chair Hôpital TenonFrance Introduction PierreRonco Speaker Hôpital TenonFrance Translational Science/Genomics ChristophKuppe Speaker Department of Nephrology, RWTH University Aachen, GermanyGermany KrzysztofKiryluk Speaker Columbia UniversityUnited States Discovery Science ReikoInagi Speaker The University of Tokyo Graduate School of MedicineJapan VeronicaMiguel Speaker Spanish National Centre for Cardiovascular ResearchSpain Crossing the Lines to ‘Acceptance’ in High Impact Kidney Journals PierreRonco Speaker Hôpital TenonFrance SumitMohan Speaker Columbia UniversityUnited States Epidemiology/Stats/Policy Forum AnnaFrancis Speaker University of QueenslandAustralia GermaineWong Speaker University of SydneyAustralia MuzamilHassan Speaker Department of Medicine, Obafemi Awolowo University, Ile-Ife, NigeriaNigeria Clinical Trials BradRovin Speaker The Ohio State UniversityUnited States Kesar Hall 202